rs148418212

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001291867.2(NHS):​c.4051G>A​(p.Asp1351Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,209,941 control chromosomes in the GnomAD database, including 2 homozygotes. There are 40 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., 9 hem., cov: 23)
Exomes 𝑓: 0.00012 ( 2 hom. 31 hem. )

Consequence

NHS
NM_001291867.2 missense

Scores

2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.44

Publications

1 publications found
Variant links:
Genes affected
NHS (HGNC:7820): (NHS actin remodeling regulator) This gene encodes a protein containing four conserved nuclear localization signals. The encoded protein functions in eye, tooth, craniofacial and brain development, and it can regulate actin remodeling and cell morphology. Mutations in this gene have been shown to cause Nance-Horan syndrome, and also X-linked cataract-40. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2014]
NHS Gene-Disease associations (from GenCC):
  • Nance-Horan syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009212434).
BP6
Variant X-17728157-G-A is Benign according to our data. Variant chrX-17728157-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 211599.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 22 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NHSNM_001291867.2 linkc.4051G>A p.Asp1351Asn missense_variant Exon 7 of 9 ENST00000676302.1 NP_001278796.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NHSENST00000676302.1 linkc.4051G>A p.Asp1351Asn missense_variant Exon 7 of 9 NM_001291867.2 ENSP00000502262.1

Frequencies

GnomAD3 genomes
AF:
0.000197
AC:
22
AN:
111796
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00133
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000113
Gnomad OTH
AF:
0.00133
GnomAD2 exomes
AF:
0.000496
AC:
91
AN:
183355
AF XY:
0.000295
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00248
Gnomad ASJ exome
AF:
0.000134
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000978
Gnomad OTH exome
AF:
0.00309
GnomAD4 exome
AF:
0.000125
AC:
137
AN:
1098145
Hom.:
2
Cov.:
32
AF XY:
0.0000853
AC XY:
31
AN XY:
363499
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26400
American (AMR)
AF:
0.00253
AC:
89
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19385
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54144
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40533
Middle Eastern (MID)
AF:
0.000483
AC:
2
AN:
4137
European-Non Finnish (NFE)
AF:
0.0000404
AC:
34
AN:
842040
Other (OTH)
AF:
0.000239
AC:
11
AN:
46094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000197
AC:
22
AN:
111796
Hom.:
0
Cov.:
23
AF XY:
0.000265
AC XY:
9
AN XY:
33974
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30712
American (AMR)
AF:
0.00133
AC:
14
AN:
10559
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2650
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3563
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2656
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6038
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000113
AC:
6
AN:
53187
Other (OTH)
AF:
0.00133
AC:
2
AN:
1506
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000261
Hom.:
2
Bravo
AF:
0.000604
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000519
AC:
63
EpiCase
AF:
0.000164
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jul 17, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Oct 28, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Nance-Horan syndrome Benign:1
Nov 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

NHS-related disorder Benign:1
Jun 26, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
11
DANN
Uncertain
1.0
DEOGEN2
Benign
0.024
.;.;T;T
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.77
T;T;T;T
M_CAP
Benign
0.0082
T
MetaRNN
Benign
0.0092
T;T;T;T
MetaSVM
Benign
-0.89
T
PhyloP100
1.4
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.1
N;N;.;.
REVEL
Benign
0.16
Sift
Benign
0.16
T;T;.;.
Sift4G
Benign
0.17
T;T;T;T
Vest4
0.13
MVP
0.25
MPC
0.36
ClinPred
0.062
T
GERP RS
4.0
gMVP
0.21
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148418212; hg19: chrX-17746277; API